Judge Overseeing McKinsey Opioid Injury MDL Dismisses Remaining Claims
July 21, 2023
DOCUMENTS
- Order
SAN FRANCISCO — The judge overseeing the federal docket for opioid-related lawsuits filed against global consulting firm McKinsey & Company Inc. has dismissed the remaining actions in the MDL brought on behalf of minors with neonatal abstinence syndrome (NAS), ruling they failed to establish a duty to use due care.
In a July 20 order, Judge Charles R. Breyer of the U.S. District Court for the Northern District of California explained that the alleged opioid exposure injuries “are not suffered by a few but rather by millions of adults and minors alike” and that the individual plaintiffs failed to …
UPCOMING CONFERENCES

HarrisMartin's Webinar Series: Suboxone (Buprenorphine/Naloxone) Film Marketing, Sales Practices and Products Litigation - MDL No. 3092
December 18, 2023

HarrisMartin's Ozempic Plaintiff Conference: An Emerging Litigation
December 01, 2023 - Charleston, SC
Plaintiff-Only Event @ The Charleston Place